Morgane Mouslim

@morghend and I discuss hospital discounted cash prices in our new @Health_Affairs blog: Does it have a utility for patients? What should researchers make of it? We share thoughts/insights & solicit feedback @CMSGov @UMBC @HilltopInstitut #hospitals healthaffairs.org/doi/10.1377/hb…

This suggests that these data sources are capturing pricing information from the same underlying contracts, as intended. Work supported by @Arnold_Ventures , authors affiliated with @UMBC and @HilltopInstitut

While @morghend and I find a relatively low degree of overlap between the two pricing data sources, when the two data sources do overlap, there is a strong level of concordance.

New study out now in @AJMC_Journal . The first research of its kind, the piece compares hospital and insurer price transparency data for for maternity-related services negotiated between @BCBSMississippi and 26 Mississippi hospitals. ajmc.com/view/cross-val… via @AJMC

As we continue to work in the evolving landscape of price transparency in healthcare, we welcome peer and stakeholder feedback and thoughts!

Excited to share our (@morghend) new study in hospital price transparency in @AJMC_Journal! We explore a crucial but understudied component of hospital pricing: hospital-insurer contracts. #PriceTransparency ajmc.com/view/facts-abo… via @AJMC

@morghend and I continue our exploration of the Transparency in Coverage regulation in a new @Health_Affairs Forefront as we ask: where are the compliance studies ? Read below for answers. @Arnold_Ventures @UMBC @HilltopInstitut healthaffairs.org/content/forefr…

Can the @CMSGov Transparency in Coverage rule be used as a new tool to promote provider gender equity? @morghend and I explore this issue in our new @Health_Affairs Forefront piece @UMBC @Arnold_Ventures @HilltopInstitut healthaffairs.org/content/forefr…

With @morghend, our new study, out now in @JournalGIM explores changing hospital compliance with @CMSGov price transparency regulation over time. Read here link.springer.com/article/10.100…

Our new study on biosimilar insulin highlights an interesting paradox: less expensive to insurers but no cost savings to patients. Out now in @AJMC_Journal. With @jlevy2 @rashidi_emaan, Mariana SoCal, and Antonio Trujillo. ajmc.com/view/the-price… via @AJMC_Journal

Hospital #pricetransparency might not change patients’ behaviors now but could ultimately change how hospitals deliver care. @drnic1 discusses #DataLiberationDay with @morghend and @MorganeMouslim #interoperability #HCupsidedown #healthcareupsidedown bit.ly/3UVNyB7

Thank you @UMBCSocSci for having @morghend and me on to discuss our research on hospital price transparency @HilltopInstitut #pricetransparency

What correlates with higher emergency room facility fees for self-pay patients? For profit status and larger bed size, for starters. Read our (@morghend) new study in @healthaffairs for full story @UMBC @HilltopInstitut healthaffairs.org/doi/10.1377/hl…

Our new article highlights key factors in biosimilar uptake in emerging markets: government pricing & procurement policies, provider & patient confidence in biosimilar efficacy tandfonline.com/doi/full/10.10… @tandfbiosci @iitdelhi @HilltopInstitut @UMBC

In their new blog, @MorganeMouslim + @morghend from @JohnsHopkinsEPI + @UMBC discuss how availability of discounted cash price data should also inform policy efforts regarding hospital pricing for the uninsured and underinsured. bit.ly/3CJum10

@morghend, I believe this is already being used to some extent (and with promising early results) in Maryland, is that correct?

Great work by @morghend and team who proposed and validated a #claims-based #prediction model which accurately flags patients at risk of an avoidable hospital event @HSR_HRET @HilltopInstitut @UMBC onlinelibrary.wiley.com/doi/abs/10.111…

Shout-out to @AndreaRMolino @KayteAndersen & @TheOriginalBRK for their incredible commentary about the emotional burden of being an epidemiologist during the COVID-19 pandemic. Check-out the full article in @AmJEpi below! academic.oup.com/aje/advance-ar…

Our (@morghend) new piece presents and assesses the challenges that the @CMSGov 's hospital price transparency rule faces. @ConversationUS @UMBC @HilltopInstitut theconversation.com/how-to-make-co… #healthcare

Accompanying piece describes how and how challenging it can be to use this data nytimes.com/2021/08/22/ups…

Collaboration with ⁦@morghend⁩ ⁦@sarahkliff⁩ ⁦@jshkatz⁩ and ⁦@adamplayford⁩ that leverages public data to shed light on hospital pricing in the US. This highlights the importance and potential of #pricetransparency. nytimes.com/interactive/20…